… , infectious disease, HIV/AIDS, and basic and clinical immunology. Some of the topics
covered include emerging and re-emerging infections, the development of infectious disease …

… Powassan virus; infectious complications of new drugs for cancer; new drugs for resistant
bacteria and mycobacteria; new guidelines for diagnosis and therapy of HIV infections; and …

… Members of the Cambridge Institute of Therapeutic Immunology and Infectious Disease-National
Institute for Health Research (CITIID-NIHR) COVID BioResource Collaboration are: …

… Our study highlights the coordinated immune response that contributes to COVID-19
pathogenesis and reveals discrete cellular components that can be targeted for therapy. …

Persistent symptoms following SARS-CoV-2 infection are increasingly reported, although
the drivers of post-acute sequelae (PASC) of COVID-19 are unclear. Here we assessed 214 …

… -CoV-2 infection, was investigated as a second outcome in the Cambridge cohort, using ad
… a published tool developed by Cambridge University Hospitals for assessing rehabilitation …

… We also thank the NIHR Cambridge Clinic Research Facility outreach team for … NIHR
Cambridge Biomedical Research Centre Cell Phenotyping Hub and the CRUK Cambridge Institute …

… Institute of Therapeutic Immunology Infectious Disease-National Institute of Health Research
(CITIID-NIHR) … Group members of Cambridge Institute of Therapeutic Immunology and …

… COVID-19 infection To delineate the immune response to COVID-19 infection, we collected
… 23 COVID-19 infection across three UK centres in Newcastle, Cambridge and London. …

In a study of 207 SARS-CoV2-infected individuals with a range of severities followed over 12
weeks from symptom onset, we demonstrate that an early robust immune response, without …